ETH-LAD 100mcg Blotters

9,00

Pay your order with Bitcoin or other Crypto Currency and get 10% discount: 8,10 (-0,90)

ETH-LAD is a structural analogue of lysergic acid with an N, N-diethylamide functional set bound to RN of this chemical structure. This heart polycyclic structure is an indole derivative also has both overlapping tryptamine and phenethylamine skeletons embedded within its molecular structure (despite the fact that it’s principally categorized as a tryptamine). ETH-LAD’s arrangement includes a bicyclic hexahydroindole fused to some bicyclic quinoline category (nor-lysergic acid).

ETH-LAD does not have a methyl group substituted at R6 of its nor-lysergic acid skeleton as is the case with LSD; this is represented with the nor- prefix. Rather, ETH-LAD is substituted at R6 with an ethyl group. At carbon 8 of the quinoline, a N,N-diethyl carboxamide is bound in precisely the same configuration of LSD.

ETH-LAD, also called (+)-D-ETH-LAD, has a complete configuration of (5R, 8R)

Availability: Out of stock

Email me when back in stock

ETH-LAD is chemically similar to LSD and has a similar mechanism of activity, acting chiefly by stimulating dopamine receptors in the brain.

It’s noted for its modified visual stimulation; comparative to LSD. It has been marketed alongside psychedelic lysergamides such as 1P-LSD and AL-LAD,

ETH-LAD has been shown to be moderate to significantly more potent than LSD itself in animal studies with an active dose reported at between 40 and 100 micrograms. Anecdotal reports suggest that while it creates similar effects to LSD at low to common doses, it displays a notably divergent effects profile in higher doses, sometimes called producing”algorithmic” and”warped” visual and auditory distortions, together with an “introspective” and”analytical”, if more”impartial” headspace.

ETH-LAD has been reported to more readily create adverse physical effects such as severe and migraines nausea, temperature dysregulation, and generalized physiological discomfort, particularly in higher doses. This has been speculated to owe to an unusually sensitive and unpredictable dose-response curve, as low to frequent dose encounters are usually described as being very manageable and non-threatening.

As with LSD and other compounds in the lysergamide household, ETH-LAD likely acts as a 5-HT2A partial agonist. The psychedelic effects are believed to come from ETH-LAD’s efficacy at the 5-HT2A receptors, although it Is Probable that such as LSD, ETH-LAD additionally binds to a Wide Selection of different receptors, such as multiple Distinct subtypes of serotonin receptors in Addition to dopamine and adrenoreceptors.

Order ETH-LAD blotters online at BezoKing.com!

Appearance

Blotter

CAS Number

65527-62-0

Chemical class

Lisergamide

Common name(s)

-Ethyl-nor-lysergic acid N,N-diethylamide, 6-ethyl-6-nor-Lysergic acid diethylamide, eth-lad, N-Ethyl-nor-LSD

InChi Key

MYNOUXJLOHVSMQ-DNVCBOLYSA-N

IUPAC name

(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9- hexahydroindolo-[4,3-fg]quinoline-9-carboxamide

SMILES

CCN(C([[email protected]@H]1C=C2C3=CC=CC4=C3C(C[[email protected]]2N(CC)C1)=CN4)=O)CC

Psychoactive class

Psychedelic

Systematic name

(6aR,9R)-N,N,7-Triethyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide

You may also like…